ESCMID* guideline for the diagnosis and treatment of biofilm infections 2014

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F15%3A00082262" target="_blank" >RIV/00216224:14110/15:00082262 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.cmi.2014.10.024" target="_blank" >http://dx.doi.org/10.1016/j.cmi.2014.10.024</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.cmi.2014.10.024" target="_blank" >10.1016/j.cmi.2014.10.024</a>

Jazyk výsledku

angličtina

Název v původním jazyce

ESCMID* guideline for the diagnosis and treatment of biofilm infections 2014

Popis výsledku v původním jazyce

Biofilms cause chronic infections in tissues or by developing on the surfaces of medical devices. Biofilm infections persist despite both antibiotic therapy and the innate and adaptive defence mechanisms of the patient. Biofilm infections are characterized by persisting and progressive pathology due primarily to the inflammatory response surrounding the biofilm. For this reason, many biofilm infections may be difficult to diagnose and treat efficiently. It is the purpose of the guideline to bring the current knowledge of biofilm diagnosis and therapy to the attention of clinical microbiologists and infectious disease specialists. Selected hallmark biofilm infections in tissues (e.g. cystic fibrosis with chronic lung infection, patients with chronic wound infections) or associated with devices (e.g.

Název v anglickém jazyce

ESCMID* guideline for the diagnosis and treatment of biofilm infections 2014

Popis výsledku anglicky

Biofilms cause chronic infections in tissues or by developing on the surfaces of medical devices. Biofilm infections persist despite both antibiotic therapy and the innate and adaptive defence mechanisms of the patient. Biofilm infections are characterized by persisting and progressive pathology due primarily to the inflammatory response surrounding the biofilm. For this reason, many biofilm infections may be difficult to diagnose and treat efficiently. It is the purpose of the guideline to bring the current knowledge of biofilm diagnosis and therapy to the attention of clinical microbiologists and infectious disease specialists. Selected hallmark biofilm infections in tissues (e.g. cystic fibrosis with chronic lung infection, patients with chronic wound infections) or associated with devices (e.g.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

EE - Mikrobiologie, virologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical Microbiology and Infection

ISSN

1198-743X

e-ISSN

—

Svazek periodika

21

Číslo periodika v rámci svazku

S1

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

25

Strana od-do

"S1"-"S25"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—